|
US20060246523A1
(en)
|
2005-04-28 |
2006-11-02 |
Christopher Bieniarz |
Antibody conjugates
|
|
CN104090095B
(zh)
*
|
2005-11-23 |
2016-06-01 |
文塔纳医疗系统公司 |
分子缀合物
|
|
DE102006011507A1
(de)
|
2006-03-14 |
2007-09-20 |
Lts Lohmann Therapie-Systeme Ag |
Wirkstoffbeladene Nanopartikel auf Basis hydrophiler Proteine
|
|
ATE509033T1
(de)
|
2006-03-20 |
2011-05-15 |
Univ California |
Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting
|
|
WO2007122259A1
(en)
*
|
2006-04-25 |
2007-11-01 |
Centre National De La Recherche Scientifique (Cnrs) |
Functionalization of gold nanoparticles with oriented proteins. application to the high-density labelling of cell membranes
|
|
EP3276349B1
(en)
|
2006-11-01 |
2019-08-07 |
Ventana Medical Systems, Inc. |
Haptens, hapten conjugates, compositions thereof and method for their preparation and use
|
|
FR2909881A1
(fr)
*
|
2006-12-14 |
2008-06-20 |
Inst Nat Sante Rech Med |
Nouveaux conjugues, utilisables a des fins therapeutiques, et/ou a titre d'agent de diagnostic et/ou d'imagerie et leur procede de preparation
|
|
WO2008147481A1
(en)
*
|
2007-02-09 |
2008-12-04 |
Northeastern University |
Precision-guided nanoparticle systems for drug delivery
|
|
US7682789B2
(en)
*
|
2007-05-04 |
2010-03-23 |
Ventana Medical Systems, Inc. |
Method for quantifying biomolecules conjugated to a nanoparticle
|
|
US7985557B2
(en)
|
2007-05-23 |
2011-07-26 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
WO2009025364A1
(ja)
*
|
2007-08-23 |
2009-02-26 |
Mitsubishi Kagaku Iatron, Inc. |
非特異反応抑制剤
|
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
|
US8551072B2
(en)
*
|
2007-12-12 |
2013-10-08 |
Boston Scientific Scimed, Inc. |
Methods, devices and compositions for controlled drug delivery to injured myocardium
|
|
US20090181183A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Xerox Corporation |
Stabilized Metal Nanoparticles and Methods for Depositing Conductive Features Using Stabilized Metal Nanoparticles
|
|
US20090270269A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Ashok Kumar |
Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants
|
|
KR101153748B1
(ko)
*
|
2008-05-07 |
2012-06-14 |
재단법인서울대학교산학협력재단 |
바이오센서로 유용한 새로운 형태의 금/은 코어쉘 복합체
|
|
CA2979353C
(en)
|
2008-06-05 |
2020-06-30 |
Ventana Medical Systems, Inc. |
Compositions comprising nanomaterials and method for using such compositions for histochemical processes
|
|
US20100069616A1
(en)
*
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
|
ES2915692T3
(es)
|
2008-08-13 |
2022-06-24 |
California Inst Of Techn |
Nanopartículas portadoras y composiciones, métodos y sistemas relacionados
|
|
US20100136584A1
(en)
*
|
2008-09-22 |
2010-06-03 |
Icb International, Inc. |
Methods for using antibodies and analogs thereof
|
|
WO2010043053A1
(en)
*
|
2008-10-15 |
2010-04-22 |
National Research Council Of Canada |
Single-domain antibody functionalized quantum dots for cellular imaging of cancer cells
|
|
JP5838169B2
(ja)
|
2009-12-31 |
2016-01-06 |
ヴェンタナ メディカル システムズ, インク. |
一意的に特異的核酸プローブを生成するための方法
|
|
USPP22463P3
(en)
*
|
2010-02-16 |
2012-01-17 |
Menachem Bornstein |
Gypsophila plant named ‘Pearl Blossom’
|
|
AU2011220792A1
(en)
|
2010-02-26 |
2012-07-26 |
Ventana Medical Systems, Inc. |
Cytogenic analysis of metaphase chromosomes
|
|
DK2539355T3
(da)
|
2010-02-26 |
2017-01-02 |
Ventana Med Syst Inc |
IN-SITU-hybridisering med polytag-prober
|
|
CA2796087A1
(en)
|
2010-04-20 |
2011-10-27 |
Ventana Medical Systems, Inc. |
Two-color chromogenic in situ hybridization
|
|
CA2792569C
(en)
|
2010-04-27 |
2019-01-15 |
Ventana Medical Systems, Inc. |
Antibody-nanoparticle conjugates and methods for making and using such conjugates
|
|
DK2588144T3
(en)
|
2010-07-02 |
2018-07-23 |
Ventana Med Syst Inc |
Detection of targets using mass markers and mass spectrometry
|
|
US20130109019A1
(en)
|
2010-07-02 |
2013-05-02 |
Adrian E. Murillo |
Hapten conjugates for target detection
|
|
US9127028B2
(en)
|
2010-08-16 |
2015-09-08 |
Ventana Medical Systems, Inc. |
Substrates for chromogenic detection and methods of use in detection assays and kits
|
|
EP3779433A3
(en)
*
|
2010-08-30 |
2021-05-19 |
Konica Minolta, Inc. |
Tissue staining method, tissue evaluation method and biosubstance detection method
|
|
CA2851101C
(en)
|
2010-10-06 |
2017-02-14 |
Biocare Medical, Llc |
Methods and systems for efficient processing of biological samples
|
|
CN103649713B
(zh)
|
2010-11-29 |
2017-03-01 |
丹麦达科有限公司 |
由可编程性定量检定所处理的样本的图像分析方法和体系
|
|
US20120148488A1
(en)
*
|
2010-12-10 |
2012-06-14 |
California Institute Of Technology |
Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
|
|
KR101779610B1
(ko)
*
|
2011-01-17 |
2017-09-18 |
엘지전자 주식회사 |
면역 센서에서 검출 신호를 증폭하기 위한 키트 및 이를 이용한 표적 항원의 검출 방법
|
|
WO2012109538A2
(en)
|
2011-02-10 |
2012-08-16 |
President And Fellows Of Harvard College |
Surrogates of post-translationally modified proteins and uses thereof
|
|
US9945763B1
(en)
|
2011-02-18 |
2018-04-17 |
Biocare Medical, Llc |
Methods and systems for immunohistochemistry heat retrieval of biological samples
|
|
US9448231B2
(en)
|
2011-02-28 |
2016-09-20 |
Ventana Medical Systems, Inc. |
Application of quantum dots for nuclear staining
|
|
US9562259B2
(en)
|
2011-03-14 |
2017-02-07 |
Ventana Medical Systems, Inc. |
Method of analyzing chromosomal inversions
|
|
KR20120128440A
(ko)
*
|
2011-05-17 |
2012-11-27 |
삼성전자주식회사 |
표적 물질 검출용 키트 및 이를 이용한 표적 물질 검출 방법
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
WO2013167387A1
(en)
|
2012-05-10 |
2013-11-14 |
Ventana Medical Systems, Inc. |
Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
|
|
JP6923291B2
(ja)
|
2012-07-12 |
2021-08-18 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
少なくとも7個の遺伝子のサインを用いて、固形癌を患う患者の生存期間および処置に対する応答性を予測するための方法
|
|
LT2880180T
(lt)
|
2012-08-06 |
2019-01-25 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Būdai ir rinkiniai, skirti vėžiu sergančių pacientų atrankai
|
|
WO2014048942A1
(en)
|
2012-09-25 |
2014-04-03 |
Ventana Medical Systems, Inc. |
Probes for pten, pik3ca, met, and top2a, and method for using the probes
|
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
|
WO2014139979A1
(en)
*
|
2013-03-12 |
2014-09-18 |
Ventana Medical Systems, Inc. |
Quantum dot in situ hybridization
|
|
DK2971064T3
(da)
|
2013-03-12 |
2019-12-16 |
Ventana Med Syst Inc |
Nærhedsassay til in situ-påvisning af mål
|
|
CN103293293B
(zh)
*
|
2013-06-24 |
2015-01-14 |
浙江大学 |
用于无标记癌胚抗原检测的电化学免疫传感器的制备方法
|
|
WO2015001082A1
(en)
|
2013-07-05 |
2015-01-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Novel alternative splice transcripts for mhc class i related chain alpha (mica) and uses thereof
|
|
WO2015026663A1
(en)
|
2013-08-19 |
2015-02-26 |
University Of Houston |
Phosphorescent reporters
|
|
WO2015036405A1
(en)
|
2013-09-10 |
2015-03-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating basal cell carcinoma
|
|
AU2015255883A1
(en)
*
|
2014-05-08 |
2016-10-27 |
Novodiax, Inc. |
Direct immunohistochemistry assay
|
|
EP3001833B1
(en)
*
|
2014-06-25 |
2019-01-23 |
Bio-Rad Laboratories, Inc. |
Purification of nanoparticle-antibody conjugates
|
|
EP3009147A1
(en)
|
2014-10-16 |
2016-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for treating resistant glioblastoma
|
|
JP6743703B2
(ja)
*
|
2014-11-06 |
2020-08-19 |
コニカミノルタ株式会社 |
免疫染色法、およびこれに用いられる免疫染色試薬キット
|
|
CN107003323B
(zh)
|
2014-11-25 |
2019-06-04 |
文塔纳医疗系统公司 |
使用化学连接和半抗原转移的邻近测定法
|
|
JP6740906B2
(ja)
*
|
2015-02-12 |
2020-08-19 |
コニカミノルタ株式会社 |
抗体結合蛍光体集積ナノ粒子、抗体結合蛍光体集積ナノ粒子の製造方法および免疫染色キット
|
|
JP6766804B2
(ja)
*
|
2015-04-07 |
2020-10-14 |
コニカミノルタ株式会社 |
核酸プローブ
|
|
WO2017001374A1
(en)
*
|
2015-06-30 |
2017-01-05 |
Imec Vzw |
Surface immobilization of an analyte-recognizing molecule
|
|
EP3317323B1
(en)
|
2015-07-01 |
2021-05-26 |
California Institute of Technology |
Cationic mucic acid polymer-based delivery systems
|
|
CN106338423B
(zh)
|
2015-07-10 |
2020-07-14 |
三斯坎公司 |
组织学染色的空间复用
|
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
|
WO2017056844A1
(ja)
*
|
2015-09-28 |
2017-04-06 |
コニカミノルタ株式会社 |
前立腺癌の病理組織診断結果(グリーソンスコア)の推定方法
|
|
WO2017055324A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of cells of monocytic origin in a tissue sample
|
|
WO2017055319A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of b cells in a tissue sample
|
|
WO2017055320A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of cytotoxic lymphocytes in a tissue sample
|
|
WO2017055325A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of nk cells in a tissue sample
|
|
WO2017055327A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of endothelial cells in a tissue sample
|
|
WO2017055321A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of fibroblasts in a tissue sample
|
|
WO2017055322A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of neutrophils in a tissue sample
|
|
WO2017055326A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of myeloid dendritic cells in a tissue sample
|
|
WO2017060397A1
(en)
|
2015-10-09 |
2017-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from melanoma metastases
|
|
WO2017067944A1
(en)
|
2015-10-19 |
2017-04-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from triple negative breast cancer
|
|
WO2017083659A1
(en)
*
|
2015-11-12 |
2017-05-18 |
New York University |
Biodegradable polymeric nanoparticle conjugates and use thereof
|
|
WO2017117275A1
(en)
*
|
2015-12-31 |
2017-07-06 |
City Of Hope |
Silica nanoparticle with platinum anti-cancer agent
|
|
WO2017182834A1
(en)
|
2016-04-19 |
2017-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating resistant glioblastoma
|
|
WO2017202962A1
(en)
|
2016-05-24 |
2017-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
|
|
CN109715196A
(zh)
|
2016-06-13 |
2019-05-03 |
转矩医疗股份有限公司 |
用于促进免疫细胞功能的组合物和方法
|
|
US20180009659A1
(en)
*
|
2016-07-05 |
2018-01-11 |
Nanoco Technologies Ltd. |
Ligand conjugated quantum dot nanoparticles and methods of detecting dna methylation using same
|
|
WO2018011107A1
(en)
|
2016-07-11 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of er-alpha 46 in methods and kits for assessing the status of breast cancer
|
|
WO2018011166A2
(en)
|
2016-07-12 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of myeloid dendritic cells in a tissue sample
|
|
WO2018046736A1
(en)
|
2016-09-12 |
2018-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from cancer
|
|
EP3295933A1
(en)
*
|
2016-09-14 |
2018-03-21 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Hydrogels based on functionalized polysaccharides
|
|
US11542371B2
(en)
|
2016-09-14 |
2023-01-03 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Hydrogels based on functionalized polysaccharides
|
|
EP3516071B1
(en)
|
2016-09-22 |
2021-02-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of lung cancer
|
|
EP3515453A1
(en)
|
2016-09-22 |
2019-07-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof
|
|
US10814305B2
(en)
*
|
2016-09-29 |
2020-10-27 |
Bio-Rad Laboratories, Inc. |
Agarose-filled ceramic apatite
|
|
WO2018118759A1
(en)
|
2016-12-19 |
2018-06-28 |
Ventana Medical Systems, Inc. |
Peptide nucleic acid conjugates
|
|
WO2018122249A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
|
|
WO2018122245A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
|
|
WO2018146239A1
(en)
|
2017-02-10 |
2018-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarker for outcome in aml patients
|
|
WO2018162404A1
(en)
|
2017-03-06 |
2018-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarker for outcome in aml patients
|
|
WO2018172540A1
(en)
|
2017-03-24 |
2018-09-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to predict the progression of alzheimer's disease
|
|
WO2018189215A1
(en)
|
2017-04-12 |
2018-10-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the survival time of a patient suffering from hepatocellular carcinoma
|
|
WO2018195008A1
(en)
|
2017-04-21 |
2018-10-25 |
Mellitus, Llc |
Methods and antibodies for diabetes-related applications
|
|
CN107389913B
(zh)
*
|
2017-06-26 |
2019-05-17 |
清华大学 |
生物传感器及生物检测方法
|
|
WO2019038219A1
(en)
|
2017-08-21 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
|
WO2019043138A1
(en)
|
2017-09-01 |
2019-03-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHOD FOR PREDICTING OUTCOME OF CANCER
|
|
CA3074826A1
(en)
|
2017-09-05 |
2019-03-14 |
Torque Therapeutics, Inc. |
Therapeutic protein compositions and methods of making and using the same
|
|
WO2019092269A1
(en)
|
2017-11-13 |
2019-05-16 |
F. Hoffmann-La Roche Ag |
Devices for sample analysis using epitachophoresis
|
|
EP3716949A4
(en)
*
|
2017-11-29 |
2022-05-18 |
UTI Limited Partnership |
METHODS OF TREATMENT OF AUTOIMMUNE DISEASES
|
|
JP7727385B2
(ja)
|
2017-12-18 |
2025-08-21 |
ヴェンタナ メディカル システムズ, インク. |
ペプチド核酸コンジュゲート
|
|
EP3755381B1
(en)
|
2018-02-21 |
2025-01-01 |
Sorbonne Université |
Optical imaging agents targeting inflammation
|
|
WO2019207030A1
(en)
|
2018-04-26 |
2019-10-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting a response with an immune checkpoint inhibitor in a patient suffering from a lung cancer
|
|
US20190381188A1
(en)
|
2018-06-13 |
2019-12-19 |
California Institute Of Technology |
Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same
|
|
EP3864403A1
(en)
|
2018-10-12 |
2021-08-18 |
F. Hoffmann-La Roche AG |
Detection methods for epitachophoresis workflow automation
|
|
WO2020089428A1
(en)
|
2018-11-02 |
2020-05-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
|
WO2020089432A1
(en)
|
2018-11-02 |
2020-05-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
|
MX2021008121A
(es)
|
2019-01-03 |
2021-12-10 |
Inst Nat Sante Rech Med |
Metodos y composiciones farmaceuticas para mejorar las respuestas inmunitarias dependientes de celulas t cd8+ en sujetos que sufren de cancer.
|
|
EP3911669A1
(en)
|
2019-01-16 |
2021-11-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Variants of erythroferrone and their use
|
|
EP3924520A1
(en)
|
2019-02-13 |
2021-12-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for selecting a cancer treatment in a subject suffering from cancer
|
|
WO2020182932A1
(en)
|
2019-03-13 |
2020-09-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New gene signatures for predicting survival time in patients suffering from renal cell carcinoma
|
|
WO2020193740A1
(en)
|
2019-03-28 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy for treating pancreatic cancer
|
|
WO2020201362A2
(en)
|
2019-04-02 |
2020-10-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
|
WO2020216832A1
(en)
|
2019-04-24 |
2020-10-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the response of antipsychotic drugs
|
|
WO2020229521A1
(en)
|
2019-05-14 |
2020-11-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for inhibiting or reducing bacterial biofilms on a surface
|
|
JP7441243B2
(ja)
|
2019-05-14 |
2024-02-29 |
エフ. ホフマン-ラ ロシュ アーゲー |
試料分析のための装置および方法
|
|
CN114072676B
(zh)
|
2019-06-03 |
2024-07-12 |
法国国家卫生及研究医学协会 |
调节治疗方案的方法
|
|
WO2021001539A1
(en)
|
2019-07-04 |
2021-01-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy to detect and treat eosinophilic fasciitis
|
|
US20220340975A1
(en)
|
2019-09-05 |
2022-10-27 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Method of treatment and pronostic of acute myeloid leukemia
|
|
EP4045686A1
(en)
|
2019-10-17 |
2022-08-24 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for diagnosing nasal intestinal type adenocarcinomas
|
|
JP7577538B2
(ja)
|
2020-02-19 |
2024-11-05 |
バイオ-ラッド ラボラトリーズ インコーポレーティッド |
ポリマー充填クロマトグラフィー樹脂を調製する方法
|
|
WO2021170777A1
(en)
|
2020-02-28 |
2021-09-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing, prognosing and managing treatment of breast cancer
|
|
EP4121768A1
(en)
|
2020-03-20 |
2023-01-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the survival time of a patient suffering from a cancer
|
|
JP2023528978A
(ja)
|
2020-06-10 |
2023-07-06 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
悪性膠芽腫のような癌の治療及び予防方法
|
|
WO2021255204A1
(en)
|
2020-06-18 |
2021-12-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy for treating pancreatic cancer
|
|
EP4172621A1
(en)
|
2020-06-30 |
2023-05-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
|
|
JP7741831B2
(ja)
|
2020-06-30 |
2025-09-18 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
術前補助療法及び根治手術後の固形がんを患っている患者の再発及び/又は死亡のリスクを予測するための方法
|
|
WO2022018163A1
(en)
|
2020-07-22 |
2022-01-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting survival time in patients suffering from cancer
|
|
WO2022064049A1
(en)
|
2020-09-28 |
2022-03-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing brucella infection
|
|
EP4232603A1
(en)
|
2020-10-20 |
2023-08-30 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Method for predicting the response to tnf inhibitors
|
|
JP2023548421A
(ja)
|
2020-11-06 |
2023-11-16 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
多のう胞性卵巣症候群(pcos)を診断および処置するための方法
|
|
WO2022136252A1
(en)
|
2020-12-21 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for prognosis the humoral response of a subject prior to vaccination
|
|
WO2022135753A1
(en)
|
2020-12-21 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for prognosis the humoral response of a subject prior to vaccination
|
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
|
EP4291897A1
(en)
|
2021-02-09 |
2023-12-20 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
New method to pronostic lung cancer
|
|
US20240159760A1
(en)
|
2021-03-17 |
2024-05-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing pancreatic cancer
|
|
WO2022207566A1
(en)
|
2021-03-29 |
2022-10-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to evaluate pancreatic cancer prognosis
|
|
EP4326903A1
(en)
|
2021-04-23 |
2024-02-28 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating cell senescence accumulation related disease
|
|
US20240316005A1
(en)
|
2021-07-05 |
2024-09-26 |
Institut National de la Santé et de la Recherche Médicale |
Gene signatures for predicting survival time in patients suffering from renal cell carcinoma
|
|
WO2023089159A1
(en)
|
2021-11-22 |
2023-05-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy targeting stroma/tumor cell crosstalk to treat a cancer
|
|
WO2023144303A1
(en)
|
2022-01-31 |
2023-08-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
|
WO2023152133A1
(en)
|
2022-02-08 |
2023-08-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing colorectal cancer
|
|
US20250035635A1
(en)
|
2022-03-17 |
2025-01-30 |
Institut National De La Sante Et De La Recherche Medicale |
Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
|
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
|
WO2024115935A1
(en)
|
2022-11-29 |
2024-06-06 |
Inserm |
Methods for the treatment of b-cell lymphoma using cd39 inhibitors
|
|
WO2024236131A1
(en)
|
2023-05-17 |
2024-11-21 |
Institut National de la Santé et de la Recherche Médicale |
Stratificate and method to treat a patient suffering from a cancer
|
|
WO2024245951A1
(en)
|
2023-05-26 |
2024-12-05 |
Institut National de la Santé et de la Recherche Médicale |
Combination of slc8a1 inhibitor and mitochondria-targeted antioxidant for treating melanoma
|
|
WO2025027127A1
(en)
|
2023-08-02 |
2025-02-06 |
Institut National de la Santé et de la Recherche Médicale |
New prognostic method of kidney failure
|
|
WO2025068340A1
(en)
|
2023-09-27 |
2025-04-03 |
Institut National de la Santé et de la Recherche Médicale |
Method to predict aml outcome
|
|
EP4788839A1
(en)
|
2023-10-03 |
2026-08-12 |
Institut National de la Santé et de la Recherche Médicale |
Methods of prognosis and treatment of patients suffering from melanoma
|
|
WO2025078632A1
(en)
|
2023-10-12 |
2025-04-17 |
Institut National de la Santé et de la Recherche Médicale |
Methods of prognosis and treatment of patients suffering from cancer
|
|
WO2025109147A1
(en)
|
2023-11-24 |
2025-05-30 |
Institut National de la Santé et de la Recherche Médicale |
Method to predict the risk of a cardiovascular event in a patient with type 2 diabetes
|
|
WO2025114473A1
(en)
|
2023-11-29 |
2025-06-05 |
Institut National de la Santé et de la Recherche Médicale |
Method for assessing diseases associated with a loss of p53 function in subjects in need thereof
|
|
WO2026013153A1
(en)
|
2024-07-10 |
2026-01-15 |
Institut National de la Santé et de la Recherche Médicale |
Methods of prognosis and treatment of patients suffering from myc-high tumors
|
|
WO2026093526A1
(en)
|
2024-10-31 |
2026-05-07 |
Institut National de la Santé et de la Recherche Médicale |
Methods of predicting cancer in patients having premalignant lesions
|